Averill Madison Master Fund, Ltd., 10% Owner, Director at Benitec Biopharma Inc. (BNTC), bought 46,141 shares at $11.24 ($539K) on 2025-12-18, disclosed to the SEC on 2025-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.24 | 1,515 | $17K | 3.2% |
| 2 | $11.24 | 8,700 | $98K | 18.1% |
| 3 | $11.48 | 2,434 | $28K | 5.2% |
| 4 | $11.48 | 13,950 | $160K | 29.7% |
| 5 | $12.08 | 2,892 | $35K | 6.5% |
| 6 | $12.08 | 16,650 |
| $201K |
| 37.3% |
| Total | $11.68 avg | 46,141 | $539K | 100% |